Caroline Mauve

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Breast cancer is the most common cancer in women worldwide. Despite the information provided by anatomopathological assessment and molecular markers (such as receptor expression ER, PR, HER2), breast cancer therapies and prognostics depend on the metabolic properties of tumor cells. However, metabolomics have not provided a robust and congruent biomarker(More)
  • 1